Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PLoS One ; 9(12): e115460, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25522365

RESUMO

Integration of open access, curated, high-quality information from multiple disciplines in the Life and Biomedical Sciences provides a holistic understanding of the domain. Additionally, the effective linking of diverse data sources can unearth hidden relationships and guide potential research strategies. However, given the lack of consistency between descriptors and identifiers used in different resources and the absence of a simple mechanism to link them, gathering and combining relevant, comprehensive information from diverse databases remains a challenge. The Open Pharmacological Concepts Triple Store (Open PHACTS) is an Innovative Medicines Initiative project that uses semantic web technology approaches to enable scientists to easily access and process data from multiple sources to solve real-world drug discovery problems. The project draws together sources of publicly-available pharmacological, physicochemical and biomolecular data, represents it in a stable infrastructure and provides well-defined information exploration and retrieval methods. Here, we highlight the utility of this platform in conjunction with workflow tools to solve pharmacological research questions that require interoperability between target, compound, and pathway data. Use cases presented herein cover 1) the comprehensive identification of chemical matter for a dopamine receptor drug discovery program 2) the identification of compounds active against all targets in the Epidermal growth factor receptor (ErbB) signaling pathway that have a relevance to disease and 3) the evaluation of established targets in the Vitamin D metabolism pathway to aid novel Vitamin D analogue design. The example workflows presented illustrate how the Open PHACTS Discovery Platform can be used to exploit existing knowledge and generate new hypotheses in the process of drug discovery.


Assuntos
Bases de Dados como Assunto , Descoberta de Drogas/organização & administração , Software , Descoberta de Drogas/métodos , Descoberta de Drogas/estatística & dados numéricos
2.
J Chem Inf Model ; 52(3): 757-69, 2012 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-22324299

RESUMO

Molecular interaction fields provide a useful description of ligand binding propensity and have found widespread use in computer-aided drug design, for example, to characterize protein binding sites and in small molecular applications, such as three-dimensional quantitative structure-activity relationships, physicochemical property prediction, and virtual screening. However, the grids on which the field data are stored are typically very large, consisting of thousands of data points, which make them cumbersome to store and manipulate. The wavelet transform is a commonly used data compression technique, for example, in signal processing and image compression. Here we use the wavelet transform to encode molecular interaction fields as wavelet thumbnails, which represent the original grid data in significantly reduced volumes. We describe a method for aligning wavelet thumbnails based on extracting extrema from the thumbnails and subsequently use them for virtual screening. We demonstrate that wavelet thumbnails provide an effective method of capturing the three-dimensional information encoded in a molecular interaction field.


Assuntos
Avaliação Pré-Clínica de Medicamentos/métodos , Modelos Moleculares , Área Sob a Curva , Ligantes , Conformação Molecular , Proteínas/metabolismo , Interface Usuário-Computador
3.
Bioorg Med Chem Lett ; 21(6): 1588-92, 2011 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-21349711

RESUMO

The discovery and evaluation of potent and long-acting oral sulfonamidopyrrolidin-2-one factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs are described. Unexpected selectivity issues versus tissue plasminogen activator in the former series were addressed in the later, delivering a robust candidate for progression towards clinical studies.


Assuntos
Benzazepinas/síntese química , Inibidores do Fator Xa , Inibidores de Serina Proteinase/química , Tetra-Hidroisoquinolinas/química , Administração Oral , Animais , Benzazepinas/administração & dosagem , Benzazepinas/farmacologia , Cristalografia por Raios X , Avaliação Pré-Clínica de Medicamentos , Estrutura Molecular , Ratos , Inibidores de Serina Proteinase/administração & dosagem , Tetra-Hidroisoquinolinas/administração & dosagem , Tetra-Hidroisoquinolinas/farmacologia
4.
J Chem Inf Model ; 49(6): 1514-24, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19453147

RESUMO

The combination of Daylight fingerprints and the Tversky coefficient is a powerful method for performing core hopping, that is, scaffold (or lead) hopping where the main structural difference between the query and bioactive target molecule is located in the central core of the molecular structure. However, a major disadvantage of this approach is the fact that a large number of false positives (in the context of core hopping) are retrieved. The tool we have developed and which is described here can be used to postprocess the hits from Daylight Tversky similarity searches by fragmenting the molecules and subsequently annotating them in a way that assists the users in removing false positives and enables them to better focus on molecules of interest. To validate our approach, we have selected four biological targets for which scaffold hopping examples have been reported. We present results from searches in databases containing published activity data and the subsequent analysis of the hits aimed at establishing the potential of our approach.


Assuntos
Avaliação Pré-Clínica de Medicamentos/métodos , Bradicinina/antagonistas & inibidores , Bases de Dados Factuais , Humanos , Canal de Potássio Kv1.5/metabolismo , Bloqueadores dos Canais de Potássio/farmacologia , Receptor CB1 de Canabinoide/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA